Purchase Order W81K0017P0715
Award Date 10/1/17
Potential Completion Date 9/30/18
Potential Value $2M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $947,520.62, was awarded by the Medical Command within the U.S. Department of Defense on October 1, 2020 for a period ending on September 30, 2021. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation....
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the delivery of required reagents to the Department of the Army Medical Command. The $2,676,584.59 firm fixed price delivery order contract has a completion date of September 30, 2018 and was awarded on April 10, 2017. The contract is not designated as a set-aside. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
- This federal contract award was made by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $887,473.92 firm fixed-price delivery order was placed against Roche's General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). It does not have a set-aside...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for in vitro diagnostic testing services. The contract, which is a Blanket Purchase Agreement (BPA) call valued at $741,441.86, was awarded by the Defense Health Agency (DHA) with a completion date of September 5, 2020. The contract has a firm fixed price pricing type and does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the delivery of required reagents to the Department of the Army Medical Command. The $3,100,924.36 Firm Fixed Price Delivery Order contract has a completion date of September 30, 2019 and was awarded on November 16, 2018. The contract does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments,...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the supply of ROCHE COBAS products. The contract, valued at $150,371.25, is a firm fixed-price purchase order awarded by the Department of the Army Medical Command. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures in vitro diagnostics, reagents, laboratory instruments, and associated products and...
- This federal contract was awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics and associated products and services. The $132,817.68 firm-fixed-price purchase order is for the delivery of ROCHE COBAS products and services. The contract has no set-aside designation and was awarded on October 1, 2019 with a completion date of October 31, 2020. Roche Diagnostics has...
- This federal contract was awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation for histology cost-per-test services. The contract is a Firm Fixed Price Delivery Order with a potential value of $1,280,000.00 and a completion date of September 30, 2019. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche...
- This federal contract award, valued at $3,300,000.00, was made by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract, which does not have a set-aside designation, is for the provision of bioactive substances. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. This award is a Blanket Purchase Agreement (BPA) call, with a firm fixed price...
- This federal contract award to Roche Diagnostics Corporation (Roche Diagnostics Corp) is for the provision of the ROCHE IMMUNO AUTOMATED MOLECULAR TESTING PLATFORM at the USAFSAM Epidemiology Laboratory, including associated kits and reagents. The contract, valued at $203,835.17, is a Blanket Purchase Agreement (BPA) call order issued under Roche's existing General Services Administration (GSA) Schedule 66-III contract for Critical Analyzers and Laboratory equipment. The contract has a 5-year...